• Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Average Rating of "Moderate Buy" from Analysts

    المصدر: Buzz FX / 07 ديسمبر 2024 02:41:09   America/Chicago


    Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Average Rating of "Moderate Buy" from Analysts Written by MarketBeat December 7, 2024 Share Link copied to clipboard. Shares of Sarepta Therapeutics, Inc.
    Read more...
شارك على،